Will Recent ET-Plus Guardrail Settlement be Death of Trinity Industries?

6/13/2015 Tuesday’s, $663 million settlement against guardrail manufacturer Trinity industries includes the largest-ever award given to a whistle-blower under the False-Claims Act, a whopping $199 million given to former competitor, Virginian Joshua Harman. Harman sued on behalf of the government claiming that Trinity defrauded taxpayers by failing to notify the Federal Highway Administration of a

Hacked Medical Pumps Could Kill You

  6/11/2015 Billy Rios, a security expert conducting research on medical devices manufactured by Hospira, found deadly serious security flaws in drug delivery pumps. In short: hacked medical pumps could kill you. Currently, there are hundreds of thousands of Hospira pumps in hospitals throughout the U.S. I wrote a piece last month regarding an FDA

Will Amendments, Leaked TPP Pharmaceutical Revelations Sway House Voters?

6/11/2015 The House of Representatives began a two-day debate on Thursday over giving President Obama “fast-track” authorization (FTA) to negotiate the 12-country Trans-Pacific Partnership (TPP) trade agreement on behalf of the U.S., leading to a congressional vote without amendments or filibusters. Friday’s expected House vote is the final hurdle the president needs after the Senate

Bharara vs. Barra: GM Criminal Probe Intensifies

6/11/2015 It looks like the U.S. Department of Justice’s criminal investigation into General Motors’ pre-recall knowledge is tightening its grip around the company, as the agency is now considering wire fraud charges against the company. Star Manhattan U.S. Attorney, Preet Bharara, and his office are leading the investigation in conjunction with the Department of Justice.

Supreme Court Case Review may Limit Class-Action Lawsuits

6/10/2015 The U.S. Supreme Court announced on Monday, June 8th that it will be reviewing a federal appeals ruling in its next term, petitioned by Tyson Foods, challenging a $5.8 million judgment against the company over unpaid work time at an Iowa pork-processing plant. While the sum of the judgment is miniscule in cases of

FDA to consider new Class of Cholesterol Drugs

6/9/2015 A new class of cholesterol drugs will undergo a preliminary review this week from a Food and Drug Administration (FDA) advisory panel. The drugs, Amgen’s Evolocumab and Alirocumab from Sanofi SA and partner, Regeneron Pharmaceuticals, block a protein called PCSK9, which can prevent the liver from eliminating bad cholesterol. Early studies show the drugs

Deutsche Bank CEOs to Resign after Years of Problems

6/8/2015 The global financial world received a huge shakeup Sunday when the co-CEOs of Deutsche Bank, one of the largest financial institutions in the world, announced their resignations. Anshu Jain and Jürgen Fitschen were essentially purged following an emergency meeting by the bank’s board of directors. Jain will be leaving on June 30th, replaced by

Regulators’ Mixed-Messages on Fracking

6/7/2015 One of the major environmental concerns since the beginning of this decade has been the use of hydraulic fracturing, or “fracking” to unearth natural gas and oil shale reserves. The process uses high-pressure water among other substances to create or to widen holes into the shale formation in order to release the gas or